702 results on '"Muramatsu, Masamichi"'
Search Results
2. Structural basis of hepatitis B virus receptor binding
3. Anti-SARS-CoV-2 gapmer antisense oligonucleotides targeting the main protease region of viral RNA
4. Chimeric provirus of bovine leukemia virus/SMAD family member 3 in cattle with enzootic bovine leukosis
5. Prolonged Gut Dysbiosis and Fecal Excretion of Hepatitis A Virus in Patients Infected with Human Immunodeficiency Virus.
6. Antiviral effect of peptoids on hepatitis B virus infection in cell culture
7. Neutralizing activity of intravenous immune globulin products against enterovirus D68 strains isolated in Japan
8. Performance evaluation of in vitro diagnostic kits for hepatitis B virus infection using the regional reference panel of Japan
9. Independent evolution of multi-dominant viral genome species observed in a hepatitis C virus carrier
10. Novel flavonoid hybrids as potent antiviral agents against hepatitis A: Design, synthesis and biological evaluation
11. IFN-γ‒Induced APOBEC3B Contributes to Merkel Cell Polyomavirus Genome Mutagenesis in Merkel Cell Carcinoma
12. Structural insights into the HBV receptor and bile acid transporter NTCP
13. Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers
14. Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen
15. RAISING is a high-performance method for identifying random transgene integration sites
16. The predicted stem-loop structure in the 3′-end of the human norovirus antigenomic sequence is required for its genomic RNA synthesis by its RdRp
17. Flavonoid-triazolyl hybrids as potential anti-hepatitis C virus agents: Synthesis and biological evaluation
18. Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
19. Efficient detection of SARS-CoV-2 RNA in the solid fraction of wastewater
20. Amino Acid Polymorphism in Hepatitis B Virus Associated With Functional Cure
21. Extracellular vesicles secreted by HBV-infected cells modulate HBV persistence in hydrodynamic HBV transfection mouse model
22. The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network
23. Loxapine inhibits replication of hepatitis A virus in vitro and in vivo by targeting viral protein 2C
24. Enterovirus A71 does not meet the uncoating receptor SCARB2 at the cell surface
25. Correction for Nakajima et al., “Biochemical and Structural Properties of Entecavir-Resistant Hepatitis B Virus Polymerase with L180M/M204V Mutations”
26. Generation of JC Polyoma Pseudovirus for High-Throughput Measurement of Neutralizing Antibodies
27. Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization
28. Non-nucleoside hepatitis B virus polymerase inhibitors identified by an in vitro polymerase elongation assay
29. Activation-induced cytidine deaminase is a possible regulator of cross-talk between oocytes and granulosa cells through GDF-9 and SCF feedback system
30. Integrin α3 is involved in non-enveloped hepatitis E virus infection
31. Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing
32. Evaluation of in vitro screening and diagnostic kits for hepatitis B virus infection
33. Activation of protein kinase R by hepatitis C virus RNA-dependent RNA polymerase
34. A versatile method to profile hepatitis B virus DNA integration
35. Hepatoviruses promote very-long-chain fatty acid and sphingolipid synthesis for viral RNA replication and quasi-enveloped virus release
36. The aryl hydrocarbon receptor–cytochrome P450 1A1 pathway controls lipid accumulation and enhances the permissiveness for hepatitis C virus assembly
37. Vitamin D derivatives inhibit hepatitis C virus production through the suppression of apolipoprotein
38. Evaluation of antiviral effects of novel NS5A inhibitors in hepatitis C virus cell culture system with full-genome infectious clones
39. Evaluation of in vitro screening and diagnostic kits for hepatitis C virus infection
40. A Target Selection of Somatic Hypermutations Is Regulated Similarly between T and B Cells upon Activation-Induced Cytidine Deaminase Expression
41. DNA Cleavage in Immunoglobulin Somatic Hypermutation Depends on de novo Protein Synthesis but Not on Uracil DNA Glycosylase
42. De novo Protein Synthesis Is Required for Activation-Induced Cytidine Deaminase-Dependent DNA Cleavage in Immunoglobulin Class Switch Recombination
43. Uracil DNA Glycosylase Activity Is Dispensable for Immunoglobulin Class Switch
44. Aberrant Expansion of Segmented Filamentous Bacteria in IgA-Deficient Gut
45. Activation-Induced Cytidine Deaminase Shuttles between Nucleus and Cytoplasm like Apolipoprotein B mRNA Editing Catalytic Polypeptide 1
46. Distribution of Human Sapovirus Strain Genotypes over the Last Four Decades in Japan: a Global Perspective
47. RNA-Editing Cytidine Deaminase Apobec-1 Is Unable to Induce Somatic Hypermutation in Mammalian Cells
48. De novo Protein Synthesis Is Required for the Activation-Induced Cytidine Deaminase Function in Class-Switch Recombination
49. Molecular characterization of AID-mediated reduction of hepatitis B virus transcripts
50. Critical Roles of Activation-Induced Cytidine Deaminase in the Homeostasis of Gut Flora
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.